"Immunoassay" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance.
| Descriptor ID |
D007118
|
| MeSH Number(s) |
E05.478.566 E05.601.470
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Immunoassay".
Below are MeSH descriptors whose meaning is more specific than "Immunoassay".
This graph shows the total number of publications written about "Immunoassay" by people in this website by year, and whether "Immunoassay" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 2004 | 0 | 2 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2010 | 3 | 4 | 7 |
| 2011 | 1 | 4 | 5 |
| 2012 | 1 | 2 | 3 |
| 2013 | 1 | 4 | 5 |
| 2014 | 1 | 2 | 3 |
| 2015 | 1 | 1 | 2 |
| 2016 | 4 | 4 | 8 |
| 2017 | 45 | 41 | 86 |
| 2018 | 56 | 39 | 95 |
| 2019 | 16 | 15 | 31 |
| 2020 | 51 | 42 | 93 |
| 2021 | 31 | 53 | 84 |
| 2022 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Immunoassay" by people in Profiles.
-
Comparison of Anti-SARS-CoV-2 S1 Receptor-Binding Domain Antibody Immunoassays in Health Care Workers Before and After the BNT162b2 mRNA Vaccine. Am J Clin Pathol. 2022 02 03; 157(2):212-218.
-
Evaluation of Three Anti-SARS-CoV-2 Serologic Immunoassays for Post-Vaccine Response. J Appl Lab Med. 2022 01 05; 7(1):57-65.
-
New-Generation Quantitative Immunoassays for SARS-CoV-2 Antibody Detection: Need for Harmonization. Ann Lab Med. 2022 01 01; 42(1):113-116.
-
Rapid Detection of Anti-SARS-CoV-2 Antibody Using a Selenium Nanoparticle-Based Lateral Flow Immunoassay. IEEE Trans Nanobioscience. 2022 01; 21(1):37-43.
-
Evaluation of Three Commercial and Two Non-Commercial Immunoassays for the Detection of Prior Infection to SARS-CoV-2. J Appl Lab Med. 2021 11 01; 6(6):1561-1570.
-
Necessity of a Standardized Reporting System of Antiphospholipid Antibody Tests: Relevance for COVID-19. Ann Lab Med. 2021 11 01; 41(6):601-603.
-
Comparison of SARS-CoV-2 Antibody Responses and Seroconversion in COVID-19 Patients Using Twelve Commercial Immunoassays. Ann Lab Med. 2021 Nov 01; 41(6):577-587.
-
Active matrix metalloproteinase-8 (aMMP-8) point-of-care test (POCT) in the COVID-19 pandemic. Expert Rev Proteomics. 2021 08; 18(8):707-717.
-
Surface Engineering of Graphene through Heterobifunctional Supramolecular-Covalent Scaffolds for Rapid COVID-19 Biomarker Detection. ACS Appl Mater Interfaces. 2021 Sep 15; 13(36):43696-43707.
-
A high-throughput microsphere-based immunoassay of anti-SARS-CoV-2 IgM testing for COVID-19 diagnostics. PLoS One. 2021; 16(9):e0248444.